While Liao et al. found no difference in serum levels of NPC2 between patients with fatty liver and healthy controls[27], they did report lower NPC2 protein levels in chronic viral hepatitis, cirrhosis, and hepatocellular carcinoma[28]. This evidence concerns the gene NPC2 and animal viral hepatitis.